NDAQ:CDTX - Post Discussion
Post by
whytestocks on Apr 26, 2024 10:30pm
Cidara Therapeutics Announces Presentations Highlighting Pha
JUST IN: $CDTX Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024 | BenzingaSAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak&...
CDTX - Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024 | Benzinga
Be the first to comment on this post